Clinical trials: Advanced Lung Squamous Cell Carcinoma

Renal Cancer, Non Small Cell Lung Cancer (NSCLC)

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

• Completed
• Age: 18 years and older
• Phase 1

The purpose of this study is to determine if a new investigational drug called Panobinostat is safe, tolerable and to obtain an initial assessment of efficacy, when given in combination with Sorafenib for the treatment of certain…

Conditions

Renal Cancer, Non Small Cell Lung Cancer (NSCLC), Soft Tissue Sarcoma

Trial name

NCT01005797

Testing

Panobinostat (LBH589), Sorafenib

Where

United States

Volunteers

38 people

Sponsor

Medical University of South Carolina